Correction: The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol by Noa Bregman, Tamara Shiner, Gitit Kavé, Roy Alcalay, Mali Gana-Weisz, Orly Goldstein, Tal Glinka, Orna Aizenstein, Dafna Ben Bashat, Yifat Alcalay, Anat Mirelman, Avner Thaler, Nir Giladi, Nurit Omer

Get full text

Differences in EEG Event-Related Potentials during Dual Task in Parkinson’s Disease Carriers and Non-Carriers of the G2019S-LRRK2 Mutation by Eden Shkury, Shani Danziger-Schragenheim, Zoya Katzir, Yael Ezra, Nir Giladi, Anat Mirelman, Inbal Maidan

Get full text

R869C mutation in molecular motor KIF17 gene is involved in dementia with Lewy bodies by Orly Goldstein, Mali Gana‐Weisz, Tamara Shiner, Reut Attar, Yael Mordechai, Yedael Y. Waldman, Anat Bar‐Shira, Avner Thaler, Tanya Gurevich, Anat Mirelman, Nir Giladi, Avi Orr‐Urtreger

Get full text

Imaging Markers in Genetic Forms of Parkinson’s Disease by Amgad Droby, Avner Thaler, Anat Mirelman

Get full text

EEG-Based Mapping of Resting-State Functional Brain Networks in Patients with Parkinson’s Disease by Sarah Leviashvili, Yael Ezra, Amgad Droby, Hao Ding, Sergiu Groppa, Anat Mirelman, Muthuraman Muthuraman, Inbal Maidan

Get full text

<i>C9orf72</i>-G₄C₂ Intermediate Repeats and Parkinson’s Disease; A Data-Driven Hypothesis by Hila Kobo, Orly Goldstein, Mali Gana-Weisz, Anat Bar-Shira, Tanya Gurevich, Avner Thaler, Anat Mirelman, Nir Giladi, Avi Orr-Urtreger

Get full text

The natural history study of preclinical genetic Creutzfeldt-Jakob Disease (CJD): a prospective longitudinal study protocol by Noa Bregman, Tamara Shiner, Gitit Kavé, Roy Alcalay, Mali Gana-Weisz, Orly Goldstein, Tal Glinka, Orna Aizenstein, Dafna Ben Bashat, Yifat Alcalay, Anat Mirelman, Avner Thaler, Nir Giladi, Nurit Omer

Get full text

<i>MAPT</i> Locus in Parkinson’s Disease Patients of Ashkenazi Origin: A Stratified Analysis by Shachar Shani, Mali Gana-Weisz, Anat Bar-Shira, Avner Thaler, Tanya Gurevich, Anat Mirelman, Nir Giladi, Roy N. Alcalay, Orly Goldstein, Avi Orr-Urtreger

Get full text

Effects of aging on cognitive and brain inter-network integration patterns underlying usual and dual-task gait performance by Amgad Droby, Amgad Droby, Amgad Droby, Eleanna Varangis, Christian Habeck, Jeffrey M. Hausdorff, Jeffrey M. Hausdorff, Jeffrey M. Hausdorff, Jeffrey M. Hausdorff, Yaakov Stern, Anat Mirelman, Anat Mirelman, Anat Mirelman, Inbal Maidan, Inbal Maidan, Inbal Maidan

Get full text

Abnormal gait and motor cortical processing in drug‐resistant juvenile myoclonic epilepsy by Inbal Maidan, Mor Yam, Sigal Glatt, Shai Nosatzki, Lilach Goldstein, Nir Giladi, Jeffrey M Hausdorff, Anat Mirelman, Firas Fahoum

Get full text

A novel performance scoring quantification framework for stress test set-ups by Tal Kozlovski, Jeffrey M. Hausdorff, Ori Davidov, Nir Giladi, Anat Mirelman, Yoav Benjamini

“…When applied to a real-world data example, an AUC of 84.35[95%CI: 70.68 − 95.13] was obtained for the STEPS framework to distinguish subjects with neurodegeneration from controls. In summary, STEPS improved screening by exploiting existing domain knowledge and state-of-the-art clinical measures. …”
Get full text

A novel performance scoring quantification framework for stress test set-ups. by Tal Kozlovski, Jeffrey M Hausdorff, Ori Davidov, Nir Giladi, Anat Mirelman, Yoav Benjamini

“…When applied to a real-world data example, an AUC of 84.35[95%CI: 70.68 - 95.13] was obtained for the STEPS framework to distinguish subjects with neurodegeneration from controls. In summary, STEPS improved screening by exploiting existing domain knowledge and state-of-the-art clinical measures. …”
Get full text

Paroxysmal Slow-Wave Events Are Uncommon in Parkinson’s Disease by Dan Z. Milikovsky, Yotam Sharabi, Nir Giladi, Anat Mirelman, Ronen Sosnik, Firas Fahoum, Inbal Maidan

Get full text